dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Almazan Moga, Ana |
dc.contributor.author | Zarzosa Martinez, Patricia |
dc.contributor.author | Vidal Marin, Isaac |
dc.contributor.author | Molist Muñoz, Carla |
dc.contributor.author | Giralt Buch, Irina |
dc.contributor.author | Soriano Fernández, Aroa |
dc.contributor.author | Segura Ginard, Miguel |
dc.contributor.author | Sánchez de Toledo Codina, Josep |
dc.contributor.author | Roma Castanyer, Josep |
dc.contributor.author | Gallego Melcón, Soledad |
dc.contributor.author | Navarro Barea, Natalia |
dc.date.accessioned | 2021-04-22T11:29:00Z |
dc.date.available | 2021-04-22T11:29:00Z |
dc.date.issued | 2017-01-24 |
dc.identifier.citation | Almazán-Moga A, Zarzosa P, Vidal I, Molist C, Giralt I, Navarro N, et al. Hedgehog Pathway Inhibition Hampers Sphere and Holoclone Formation in Rhabdomyosarcoma. Stem Cells Int. 2017;2017:7507380. |
dc.identifier.issn | 1687-9678 |
dc.identifier.uri | https://hdl.handle.net/11351/5902 |
dc.description | Tumors dels teixits tous; Via Hedgehog; Rabdomiosarcoma |
dc.description.sponsorship | The authors wish to thank Dr. Noel Monks (MedImmune) for the kind gift of the blocking antibody MEDI-5304 and Ms. Christine O’Hara for help with the English version of this manuscript. This work was supported by grants from Institut Català d’Oncologia (ICO), Instituto de Salud Carlos III (RTICC-RD12/0036/0016 and RD12/0036/0027; PI11/00740 and PI14/00647), Fundació A. BOSCH, and ajuts predoctorals VHIR. |
dc.language.iso | eng |
dc.publisher | Hindawi |
dc.relation.ispartofseries | Stem Cells International;2017 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Tumors de parts toves |
dc.subject | Cèl·lules canceroses |
dc.subject.mesh | Rhabdomyosarcoma |
dc.subject.mesh | Neoplastic Stem Cells |
dc.subject.mesh | Rhabdomyosarcoma |
dc.title | Hedgehog Pathway Inhibition Hampers Sphere and Holoclone Formation in Rhabdomyosarcoma |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1155/2017/7507380 |
dc.subject.decs | rabdomiosarcoma |
dc.subject.decs | células madre neoplásicas |
dc.subject.decs | rabdomiosarcoma |
dc.relation.publishversion | https://www.hindawi.com/journals/sci/2017/7507380/ |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Almazán-Moga A, Zarzosa P, Vidal I, Molist C, Giralt I, Navarro N, Soriano A, Segura MF, Roma J] Grup de Recerca translacional en càncer infantil, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Sánchez de Toledo J, Gallego S] Grup de Recerca translacional en càncer infantil, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Oncologia i Hematologia Pediàtriques, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 28243259 |
dc.identifier.wos | 000394217900001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/1PN/2008-2011/RD12%2F0036%2F0016 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/2PN/2008-2011/PI11%2F00740 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI14%2F00647 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |